AntiviralsDevelopment of drug resistance: 13 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1734卷 / 1期

关键词：

D O I：

10.1007/s40278-019-56187-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：62 / 62

相关论文

共 50 条

[41] Multiple drugsAcquired drug resistance: 3 case reports
Reactions Weekly, 2024, 2035 (1) : 292 - 292
[42] Gefitinib/osimertinibAcquired drug resistance: 3 case reports
Reactions Weekly, 2023, 1948 (1) : 215 - 215
[43] Afatinib/gefitinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2018, 1708 (1) : 28 - 28
[44] Pertuzumab/trastuzumabAcquired drug resistance: 3 case reports
Reactions Weekly, 2019, 1778 (1) : 377 - 377
[45] Multipe drugsAcquired drug resistance: 2 case reports
Reactions Weekly, 2020, 1817 (1) : 218 - 218
[46] Multiple drugsAcquired drug resistance: 11 case reports
Reactions Weekly, 2021, 1881 (1) : 170 - 170
[47] AntineoplasticsLack of efficacy and drug resistance: 3 case reports
Reactions Weekly, 2022, 1920 (1) : 57 - 57
[48] Ceftazidime/meropenemEmerging drug resistance: 2 case reports
Reactions Weekly, 2015, 1580 (1) : 94 - 94
[49] Ciprofloxacin/rituximabHypogammaglobulinaemia and drug resistance: 11 case reports
Reactions Weekly, 2021, 1837 (1) : 164 - 164
[50] Ceftolozane/tazobactamDevelopment of drug resistance: 5 case reports
Reactions Weekly, 2021, 1840 (1) : 114 - 114

← 1 2 3 4 5 →